The American Society of Hospital Pharmacists (ASHP) has also noticed this trend in drug packaging. In order to reduce prescription drug injuries, the ASHP recommends that drug manufacturers:
- Involve pharmacists, nurses, physicians and the U.S. Food and Drug Administration when making decisions about drug names, labeling, and packaging.
- Check current trademarked and generic names for possible look-alike or sound-alike errors before making a final decision on a new drug name.
- Ensure that new drug packaging is not too similar to any trademarked or generic drug on the market.
- Highlight any special instructions or warnings on the package labeling.
- Design the product label with respect to patients. For example, the product name and strength should be more prominent than company names or logos.
- Make all measureable drugs available in unit-of-dispensing containers (such as premeasured single-use syringes) when possible.
- Clearly differentiate between bulk and single packaging when multiple dosage forms of a medication are available.
- Communicate any product changes, such as dosage forms, interactions or side effects, with health-care providers and drug reporting agencies.
Our board-certified dangerous drug attorneys have handled enough prescription drug error lawsuits to know that companies rarely want to own up to their mistakes. Whether you were injured by a pharmacist’s error or because a drug company put your life at risk, the law team at Kennedy Hodges can get you the compensation you need to heal.
Call us today at 888-526-7616 for a free case consultation. If you would like more information on your injury, click the link above and we’ll rush you a FREE copy of our book, How to Make Pharmacies Pay for Injuries Caused by Medication Errors.